Drug Discovery Today, Journal Year: 2024, Volume and Issue: 29(7), P. 104019 - 104019
Published: May 8, 2024
Language: Английский
Drug Discovery Today, Journal Year: 2024, Volume and Issue: 29(7), P. 104019 - 104019
Published: May 8, 2024
Language: Английский
Nanoscale, Journal Year: 2023, Volume and Issue: 15(27), P. 11346 - 11365
Published: Jan. 1, 2023
The review systematically summarizes the applications of RNA-cleaving DNAzymes in recent years, explaining uniqueness and superiority biosensing gene therapy.
Language: Английский
Citations
11International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 257, P. 128656 - 128656
Published: Dec. 6, 2023
Language: Английский
Citations
11Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 495, P. 153209 - 153209
Published: June 21, 2024
Language: Английский
Citations
4Biomaterials, Journal Year: 2025, Volume and Issue: 317, P. 123100 - 123100
Published: Jan. 9, 2025
Language: Английский
Citations
0Analytical Chemistry, Journal Year: 2025, Volume and Issue: unknown
Published: March 11, 2025
The lack of precise, real-time analytical tools for monitoring tumor microenvironment changes during treatment hinders advancements in integrated diagnostic and therapeutic platforms. Traditional caspase-3 strategies are limited by their inability to address drug resistance newly discovered apoptotic pathways, leading reduced accuracy practicality. To overcome these limitations, we developed a fluorescence-based "Trojan horse" nanosystem, PFpR@CM, featuring high-sensitivity Caspase-1 detection, tumor-targeted delivery, photothermal therapy. was selected as biomarker due its ability provide accurate feedback on reactive oxygen species (ROS) generation. system employs Fe-doped polydopamine nanoparticles red fluorescent carbon quantum dots (RCQDs) the core, achieving detection limit 0.024 U/mL with linear range 0.05-1.0 U/mL. By integrating MG-63 cell membrane camouflage, PFpR@CM ensures specificity immune evasion, allowing precise situ ROS production ferroptosis. Experimental results demonstrate that enables simultaneous fluorescence tracking localized interventions, over 80% volume reduction vivo minimal systemic toxicity. This work establishes novel chemistry approach multifunctional treatment, providing an innovative solution challenges precision oncology.
Language: Английский
Citations
0Archives of Pharmacal Research, Journal Year: 2025, Volume and Issue: unknown
Published: March 22, 2025
Language: Английский
Citations
0Environmental Chemistry and Ecotoxicology, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
0Journal of Controlled Release, Journal Year: 2025, Volume and Issue: unknown, P. 113786 - 113786
Published: April 1, 2025
Language: Английский
Citations
0Advanced Science, Journal Year: 2024, Volume and Issue: 11(32)
Published: June 23, 2024
Abstract Photoimmunotherapy faces challenges due to insufficient intratumoral accumulation of photothermal agents and the reversion cancer‐immunity cycle during treatment. In this study, an anti‐PD‐L1‐immobilized magnetic gold nanohut, AuNH‐2‐Ab, with photoresponsive, thermosensitive, immunomodulatory properties effectively suppress growth primary tumors, elevate immunogenic cell death (ICD) levels, reverse tumor immune microenvironment (TIME), consequently inhibit metastases are developed. AuNH‐2‐Ab achieves high (9.54% injected dose) following systemic administration, allowing modulation hyperthermia dose over 50 °C in tumor. By optimizing dose, simultaneously target eliminate cancer cells tumor‐associated macrophages, thereby activating potent antitumor immunity without being compromised by immunosuppressive elements. Hyperthermia/pH induced morphological transformation involving detachment surface antibody for situ PD‐L1 inhibition, exposure inner fucoidan layer natural killer (NK) activation. This precision photoimmunotherapy approach reprograms TIME, significantly prolongs survival a murine hepatocellular carcinoma model (Hep55.1c), harnesses synergistic effects ICD production checkpoint inhibitors utilizing single nanoplatform.
Language: Английский
Citations
3Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 494, P. 153171 - 153171
Published: June 15, 2024
Language: Английский
Citations
2